|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/506 | |
| A61K 9/16 | |||
| A61K 9/20 | |||
| A61P 11/00 | |||
| A61P 15/00 | |||
| A61P 35/00 | |||
| A61P 43/00 |
| (11) | Number of the document | 3091981 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15701875.5 |
| Date of filing the European patent application | 2015-01-09 | |
| (97) | Date of publication of the European application | 2016-11-16 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/010810 |
| Date | 2015-01-09 |
| (87) | Number | WO 2015/106096 |
| Date | 2015-07-16 |
| (30) | Number | Date | Country code |
| 201461925467 P | 2014-01-09 | US |
| (72) |
PADVAL, Mahesh, US
NKANSAH, Paul, Okwabi, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
Verastem, Inc., 117 Kendrick Street Suite 500, Needham, MA 02494, US |
| (54) | COMPOSITIONS AND METHODS FOR TREATMENT OF ABNORMAL CELL GROWTH |
| COMPOSITIONS AND METHODS FOR TREATMENT OF ABNORMAL CELL GROWTH |